The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...

The global cell culture market is projected to grow at a CAGR of 12% from 2025 to 2030. This growth is driven by increasing ...

The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the ...

Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $240 from $260 but keeps a Buy rating ...

Shares of Danaher Corp. DHR rallied 2.21% to $196.31 Wednesday, on what proved to be an all-around positive trading session ...

We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to ...

The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.

Q1 2025 Earnings Call Transcript April 22, 2025 Danaher Corporation beats earnings expectations. Reported EPS is $1.88, ...

Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - ...

Danaher Corporation’s DHR share price has surged by 6.12%, which has investors questioning if this is right time to sell.

Danaher Corporation (DHR) stock slips as the company projects in line earnings guidance despite better than expected Q1 2025 financials. Read more here.

Stripping out certain one-time items, earnings came in at $1.88 a share. Analysts polled by FactSet had expected $1.63 a share. Sales edged down to $5.74 billion from about $5.8 billion. Analysts ...